Apnimed

US · APMD #3463 by market cap Listed 2026

17.90 -0.15 -0.80%

Live - 5344 symbols - heartbeat 349s ago · 2026-10-08 09:58

Pre-market 18.03 -0.06%

After-hours 18.04 0.00%

Overnight 17.47 -3.16%

Market cap: 744.98M
P/E (TTM): 4.59
P/B: -4.23
EPS: -3.22
Div yield: 0.00%
52W pos: 9%

Reader sentiment Are you bullish or bearish on APMD?

Anonymous reader poll. Unscientific, not investment advice.

About Apnimed

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Founded: 2017
Employees: 65
Headquarters: Cambridge, Massachusetts, United States of America
Fiscal year end: 12-31
Website: apnimed.com

Company profile

Exchange: US
Symbol: APMD
Market-cap rank: #3463
Listing date: 2026-07-31
Market cap: 744.98M
Float cap: 214.74M
Shares out: 41.63M
Float shares: 12.00M

Sectors & themes

Biotechnology IPOs

Browse all sectors & themes

Quote time 2026-10-08 09:58:32 · For reference only, not investment advice and not tailored to your situation.